Objectives: To monitor antiviral drug resistance among seasonal influenza viruses isolated in Korea during the 2008e2009 influenza season, we examined influenza isolates collected through Korea Influenza Surveillance Scheme for antiviral drug susceptibility. Methods: For genetic analysis of antiviral drug resistance, the matrix (M2) and neuraminidase (NA) genes of each isolate were amplified by reverse transcription-polymerase chain reaction and followed by nucleotide sequencing. For phylogenetic analyses, the sequences of hemagglutinin (HA) and NA genes of each isolate were aligned using multiple alignment program. For phenotypic analysis of antiviral drug resistance, drug susceptibilities against M2 inhibitor (amantadine) and NA inhibitors (oseltavimir and zanamivir) were determined by virus yield reduction assay and fluorometric NA inhibition assay, respectively.
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Introduction
Influenza spreads around the world in seasonal epidemics, resulting in the deaths of 250,000e500,000 people every year [1] In this study, we tested 534 (18.5%, 534/2,880) influenza A (H1N1) viruses among 2880 influenza A (H1N1) viruses isolated throughout the country by the Korean Influenza Surveillance Scheme (KISS) during the 2008e2009 influenza season. For genetic analysis of M2 gene, we analyzed the amino acid substitutions at positions 26, 27, 30, 31, or 34 within the transmembrane domain of the M2 protein, known to confer resistance to amantadine [11] . For genetic analysis of NA gene, we also analyzed influenza A (H1N1) virus for amino acid substitutions at positions 119, 136, 223, 275, 293, and 295 of the NA gene (N1 numbering), known to confer resistance to neuraminidase inhibitor drugs [12, 13] . We also phylogenetically analyzed both HA1 and NA sequences in the influenza A (H1N1) viruses.
Here we described the high rate of oseltamivirresistant influenza A (H1N1) viruses identified from influenza surveillance in Korea during the 2008e2009 influenza season and the circulation of these viruses globally based on the sequence data.
Materials and Methods

Viruses
Influenza isolates obtained by KISS from Week 36 of 2008 to Week 35 of 2009 were used in this study. Viruses were randomly selected by region and date, and 534 A (H1N1) viruses were tested for genotype and phenotype resistant to amantadine and neuraminidase inhibitors (oseltamivir and zanamivir).
Viruses were propagated in Madin-Darby Canine Kidney (MDCK) cells in Dulbecco's modified essential medium (DMEM) supplemented with 5% fetal bovine serum at 35 C and with 5% CO 2 . Viral stocks were stored at e70 C.
Extraction of viral RNA
Viral RNA was extracted from 140 mL of virus culture using a total RNA isolation kit and a QuickGene-810 instrument (Fujifilm, Tokyo, Japan) according to the manufacturer's instructions. RNA was eluted in 50 mL of the elution buffer provided in the kit and either used directly in reverse transcription polymerase chain reaction (RT-PCR) or stored at e70 C.
RT-PCR for the M2, NA, and HA genes
Detailed methods of RT-PCR for the M2, NA, and HA genes are described in the Supplementary Methods online.
Sequence analysis
The PCR products were purified for sequencing by using PCR product purification kit (Qiagen, Hilden, Germany). Both strands were sequenced by an automated method with fluorescent dideoxy-chain terminators (Applied Biosystems, Foster City, USA). At least two corresponding electropherograms for the M2, NA, and HA regions were analyzed. The sequences were aligned with the MegAlign program (DNASTAR Inc. Software, Madison, WI, USA). We analyzed the established M2 inhibitor resistance markers (26, 27, 30, 31, or 34 of M2 protein) and NA inhibitor resistance markers (119, 136, 223, 275, 293, and 295 of the NA protein in N1 numbering) in influenza viruses. We also phylogenetically analyzed the HA1 and NA coding regions in the influenza A (H1N1) virus by using MEGA with the neighbor-joining method [14] . The nucleotide sequences Oseltamivir-resistant seasonal A (H1N1) virus in Koreaof the Korean isolates used in this study were compared with those of the WHO recommended vaccine strains and other reference strains from GenBank (National Center for Biotechnology Information, NCBI).
Neuraminidase inhibition assay
Fluorescence-based neuraminidase inhibition (NI) assay according to the WHO Collaborating Centre for Reference and Research on Influenza manual was conducted using 405 influenza A (H1N1) viruses isolated in Korea during the 2008e2009 season. A detailed method of the neuraminidase inhibition assay is described in the Supplementary Methods online. (Table 1) . Influenza A (H1N1) viruses (n Z 405) were also investigated by phenotypic analysis using fluorescence-based neuraminidase inhibitor (NI) assay. Among these, all the H275Y resistant isolates (n Z 404) were resistant to oseltamivir (mean IC 50 : 643.4), while still susceptible to zanamivir (mean IC 50 : 0.53). The data from NI assay correlated 100% for virus genotypes and was identified by sequencing.
Amantadine resistance
Influenza A viruses resistance to amantadine were analyzed by the sequencing of M2 region. We randomly Table 2 ). Our data showed that all resistant viruses contained the S31 N substitution in the M2 protein known to confer amantadine resistance [10] . Other drug-resistant M2 mutations at positions 26, 27, 30, and 34 were not detected in these resistant isolates. The amantadine resistance identified by sequencing was confirmed by virus yield reduction assay. The data from the biologic assay correlated 100% for virus genotypes identified by sequencing (data not shown). Figure 2B ). In Korea, most A/Brisbane/59/2007-like viruses isolated from the 2008À2009 season were distinctly grouped on phylogenetic tree, which was characterized by two amino-acid changes, S141 N and G185A, in the HA genes (Figure 2A, triangle) . The mutations in the HA genes were corresponded to four unique nucleotide changes: A123 G, T243A, C852 T, and A1080 G in NA genes (numbering from start codon of NA gene). This is depicted in Figure 2B (asterisk). Besides S141 N and G185A in the HA1 coding region, only a few isolates had S141 K, N183S/G185S, or G185 V/H192R variations. Of isolates containing S141 N and G185A were in the HA1 coding region, some isolates additionally harbored I184 M in the HA1 coding region and G41R or T467I in the NA coding region.
Phylogenetic analysis of HA and NA genes
Discussion
To monitor the drug resistance of influenza A viruses, we performed genetic and phenotypic analyses of the NA and M2 genes of Korean isolates during the 2008e2009 season (Table 2) . For oseltamivir and zanamivir resistance, a total of 829 influenza A viruses [15] . To investigate whether these oseltamivir resistant viruses might be transmitted from abroad, we examined travelers who suspected influenza-like illness coming through Incheon International Airport in South Korea. Of 15 specimens collected at the airport during January to March 2009, six A (H1N1) and three A (H3N2) viruses were isolated. The A (H1N1) viruses were isolated from travelers who visited Hong Kong, Kazakhstan, the Philippines, and Thailand. Through a sequence analysis of the HA and NA genes, all A (H1N1) viruses were identified as the oseltamivir resistant viruses and all A (H3N2) viruses were not. Furthermore, the sequences of these A (H1N1) viruses were grouped together with most of Korean A (H1N1) isolates (Figure 2, arrows) . It revealed that the resistant A (H1N1) viruses could be introduced into Korea by travelers coming from these foreign countries.
Based on the phylogenetic analysis of the HA and NA genes, this emergence of oseltamivir-resistant influenza A (H1N1) virus in Korea coincided with the dominant circulation of this virus during the 2007e2008 season in Europe [4] . Figure 2B ) [4, 5] . This suggests that the oseltamivir resistant viruses first emerged in Europe in November 2007 and circulated globally to many countries, including the United States, Canada, South Africa, Australia, and Japan, and then would spread to Korea in November 2008 [4e9]. These oseltamivir-resistant viruses are easily transmissible and circulate independently of drug use. It suggests that the genetic variations of the HA and NA genes may contribute to their overall fitness and transmissibility.
Here, our data provide the information on the adequate use of antiviral drugs in a rapid manner for influenza treatment through antiviral resistance monitoring. Thorough monitoring of antiviral resistance in influenza viruses is therefore an essential part of influenza virus surveillance and is needed to track the emergence and worldwide spread of drug-resistant viruses.
